Arkolith/Insider Trading/TARA/Form 4

Zummo Jacqueline

Chief R&D OfficerProtara Therapeutics, Inc. (TARA) · full profile →Form 4 · filed Apr 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6K
Net Open-Market Flow
-$6K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 8, 2026Sell(S)1K$5.40$6K95K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-042079) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML